TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy (Q6628336)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy |
scientific article; zbMATH DE number 7934759
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy |
scientific article; zbMATH DE number 7934759 |
Statements
TITE-BOIN12: a Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy (English)
0 references
29 October 2024
0 references
Bayesian adaptive design
0 references
dose finding
0 references
dose optimization
0 references
risk-benefit trade-off
0 references
0 references
0 references
0 references
0 references
0 references
